Skip to content
Review Open access

A narrative review of in vitro studies on the role of reactive oxygen species in aggravating high-grade serous ovarian cancer development

Jul 2026 · Frontiers in Oncology · Vol 16 · 0 citations · 44 references
Medicine

TL;DR

This review includes 19 in vitro studies and seeks to mechanistically summarize how reactive oxygen species (ROS) reinforce the tumorigenic program from the early stages of ovarian carcinogenesis to tumor progression, metastasis, and treatment resistance.

Abstract

Ovarian cancer is often diagnosed at an advanced stage because its early symptoms are nonspecific, and the prognosis remains poor due to frequent recurrence and the development of drug resistance even after standard treatment. This review includes 19 in vitro studies and seeks to mechanistically summarize how reactive oxygen species (ROS) reinforce the tumorigenic program from the early stages of ovarian carcinogenesis to tumor progression, metastasis, and treatment resistance. Collectively, the selected studies suggest that exposure to environmental toxicants can increase ROS levels in ovarian epithelial cells, accompanied by inflammatory responses and elevated DNA damage markers, thereby creating a carcinogenesis-priming environment. During the progression stage, hypoxia, hormones, growth factors, and lipid signaling repeatedly activate survival and growth pathways, such as those involving HIF-1α/VEGF, JAK/STAT3, and AKT/mTOR, through ROS-mediated mechanisms to promote tumor cell proliferation, anti-apoptotic activity, and angiogenesis. In addition, ROS are associated with alterations in epithelial-to-mesenchymal transition-related markers, remodeling of the extracellular matrix, and regulation of matrix metalloproteinases, which enhance the metastatic and invasive potential of tumor cells. In the therapeutic context, ROS have been suggested to contribute to platinum-based chemotherapy resistance through mechanisms including changes in mitochondrial dynamics, activation of the DNA damage response, and reprogramming of ROS-dependent phosphorylation networks. Understanding the diverse molecular mechanisms and clinical manifestations associated with ROS expression in high-grade serous ovarian cancer (HGSOC) will contribute to a more precise understanding of its pathophysiology. Furthermore, studies on redox-targeted therapeutic strategies, particularly the application of mitochondria-targeted antioxidants, may provide valuable translational insights for the treatment of ovarian cancer and other ROS-related diseases.

Read PDF

Similar papers

Review Open access Sep 2026

Redox Regulation in Glioblastoma: Mechanisms, Biomarkers, and Therapeutic Implications

The potential of understanding oxidative stress mechanisms to develop therapeutic strategies that target redox balance and homeostasis, aiming to overcome resistance and improve survival outcomes for glioblastoma patients is discussed.

Salma Lamrabet, A. Houssaini, Sanae Bennis et al. · 0 citations
Review Open access Aug 2026

Oxidative stress and cancer: current insights and therapeutic implications

Oxidative stress good or evil? Oxidative stress occurs when the balance between reactive oxygen species (ROS) and antioxidant defenses shifts toward an excess of ROS; while essential in physiological processes, it plays a context-dependent role in cancer, contributing to both the promotion and inhibition of tumorigenes...

María Escribano-Cebrián, M. Bataller, M. Biasini et al. · 0 citations
Review Open access Sep 2026

Reactive Oxygen Species in Breast Cancer: From Redox Dysregulation to ROS‐Responsive Therapeutics

Breast cancer is the most frequently diagnosed malignancy among women worldwide, with 2.3 million new cases and approximately 670,000 deaths reported in 2022 alone. Despite advances in therapy, metastasis and acquired drug resistance remain major clinical challenges. Reactive oxygen species (ROS) play a dual role in br...

Marija Nikolovska, R. Stojchevski, A. Eftimov et al. · 0 citations
Review Aug 2026

Melatonin in lung cancer: integrating molecular mechanisms, tumor microenvironment regulation, apoptotic signaling, and therapeutic opportunities.

Melatonin (MLT), an endogenous indoleamine involved in circadian regulation, has emerged as a potential anticancer molecule due to its pleiotropic effects on tumor biology, and emerging evidence suggests that MLT may enhance the sensitivity of LC cells to conventional therapies through modulation of cellular stress res...

Jun Wu, Hong-Mei Kang, Yu Huang et al. · 0 citations
Review Open access Sep 2026

The 5-Lipoxygenase Pathway in Ovarian Cancer: Mechanisms of Metastasis, Chemoresistance, and Translational Targeting

Abstract Ovarian cancer remains one of the most lethal gynecologic malignancies, characterized by early peritoneal dissemination, extensive microenvironmental remodeling, and frequent emergence of chemoresistance. Beyond genetic alterations, dysregulated lipid mediator signaling represents a regulatory layer that links...

Ming-Jun Li, Xin-Yu Zhu, Lin Gan et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.